In the last decade, conventional therapy, including disease‐modifying antirheumatic drugs (DMARDs) such as methotrexate (MTX), and biological therapy, including cytokine therapy such as TNF‐α inhibitors (TNF‐αi) have been used for the treatment of RA patients.2 Here, TNF is linked to rheumatoid arthritis.